Zhejiang Wecome Pharmaceutical Company Limited (SHE:300878)

China flag China · Delayed Price · Currency is CNY
27.50
+1.05 (3.97%)
Apr 29, 2026, 3:04 PM CST
94.35%
Market Cap 3.91B
Revenue (ttm) 225.27M
Net Income (ttm) -227.34M
Shares Out 142.05M
EPS (ttm) -1.57
PE Ratio n/a
Forward PE n/a
Dividend 0.14 (0.53%)
Ex-Dividend Date n/a
Volume 2,383,900
Average Volume 1,642,310
Open 25.28
Previous Close 26.45
Day's Range 25.28 - 28.29
52-Week Range 13.86 - 37.11
Beta 0.52
RSI 52.37
Earnings Date Apr 29, 2026

About SHE:300878

Zhejiang Wecome Pharmaceutical Company Limited engages in the research and development, production, and sale of modern traditional Chinese and western medicine in China. The company offers products in various forms, including hard capsules, tablets, granules, soft capsules, pills, and other dosage forms. It also operates the retail of pharmaceutical commercial products. The company was formerly known as Zhejiang Weikang Pharmaceutical Co., Ltd. Zhejiang Wecome Pharmaceutical Company Limited was founded in 2000 and is based in Lishui, China. [Read more]

Industry Biotechnology
Sector Healthcare
Founded 2000
Employees 650
Stock Exchange Shenzhen Stock Exchange
Ticker Symbol 300878
Full Company Profile

Financial Performance

In 2025, SHE:300878's revenue was 225.27 million, a decrease of -35.86% compared to the previous year's 351.20 million. Losses were -227.34 million, 54.2% more than in 2024.

Financial Statements

News

There is no news available yet.